🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple sclerosis is the most common inflammatory disease of the central n...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-10-01
Trial ID
NCT04767698
Treatments Being Tested
This pilot study will establish a proof of concept for using a systems biol...
Status
Completed
Location
Providence Neurological Specialties West
Start Date
2020-05-11
Trial ID
NCT05081700
Treatments Being Tested
The purpose of this prospective, multicenter, open-label, efficacy, and saf...
Status
Completed
Location
St George Hospital
Start Date
2016-09-09
Trial ID
NCT02861014
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of Ocreliz...
Status
Completed
Location
Qaem International Hospital
Start Date
2019-08-19
Trial ID
NCT04966338
Treatments Being Tested
The DanNORMS study is a phase 3, non-inferiority clinical trial examining w...
Status
Active Not Recruiting
Location
Danish Multiple Sclerosis Center, Rigshospitalet
Start Date
2021-04-28
Trial ID
NCT04688788
Treatments Being Tested
This is a randomized, double blind, controlled, parallel group, multicenter...
Status
Active Not Recruiting
Location
Alabama Neurology Associates
Start Date
2020-12-03
Trial ID
NCT04548999
Treatments Being Tested
This study is designed to determine whether symptom burden differs by time ...
Status
Completed
Location
Elliot Lewis Center for Multiple Sclerosis Care
Start Date
2020-10-26
Trial ID
NCT04855617
Treatments Being Tested
The goal of this clinical trial is to learn if drug CYB704, a proposed bios...
Status
Active Not Recruiting
Location
Sandoz Investigational Site
Start Date
2025-06-10
Trial ID
NCT06847724
Treatments Being Tested
This study will evaluate the efficacy and safety of ocrelizumab (Ocrevus®) ...
Status
Active Not Recruiting
Location
Georgetown University Medical Center
Start Date
2019-08-12
Trial ID
NCT04035005
Treatments Being Tested
This is a prospective, multicenter, open-label, single-arm, phase 3b study ...
Status
Terminated
Location
University of California Irvine
Start Date
2017-03-24
Trial ID
NCT03085810
Treatments Being Tested